NCT03738696

Liposomal Bupivacaine in Rotator Cuff Repair

Efficacy of Liposomal Bupivacaine in Arthroscopic Rotator Cuff Repair

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 64 (actual)
• Sponsor: University of Alabama at Birmingham · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

To assess the efficacy of interscalene liposomal bupivacaine in controlling postoperative pain scores, oral morphine equivalents and sleep quality after arthroscopic rotator cuff repair surgery as compared to interscalene catheter.

Conditions

• Rotator Cuff Injury

Interventions

Type	Name	Description
DRUG	Exparel	A long-acting injectable sodium channel blocker bound to lipid that is indicated in controlling postoperative pain
DRUG	Ropivacaine	A short-acting injectable sodium channel blocker bound to lipid that is indicated in controlling postoperative pain

Timeline

• Start date: 2019-12-15
• Primary completion: 2022-01-01
• Completion: 2022-01-01
• First posted: 2018-11-13
• Last updated: 2024-05-16
• Results posted: 2024-05-16

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study